Stevanato Group (NYSE:STVN) Director Sells €41,084.05 in Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Elisabetta Magistretti sold 2,045 shares of Stevanato Group stock in a transaction dated Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €41,084.05. Following the sale, the director owned 2,930 shares of the company’s stock, valued at €58,863.70. The trade was a 41.11% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Stevanato Group Stock Performance

Shares of NYSE:STVN opened at €21.27 on Thursday. The firm’s 50 day simple moving average is €18.93 and its 200-day simple moving average is €17.01. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. Stevanato Group S.p.A. has a one year low of €12.89 and a one year high of €28.00. The firm has a market cap of $6.44 billion, a PE ratio of 37.98, a price-to-earnings-growth ratio of 1.76 and a beta of 0.77.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on STVN shares. Wolfe Research assumed coverage on Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 target price for the company. Weiss Ratings raised Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Finally, TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Stevanato Group currently has a consensus rating of “Buy”.

Hedge Funds Weigh In On Stevanato Group

A number of hedge funds and other institutional investors have recently modified their holdings of the business. State of Wyoming raised its stake in Stevanato Group by 39,216.7% in the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after buying an additional 2,353 shares in the last quarter. GW&K Investment Management LLC boosted its position in Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after acquiring an additional 1,055 shares in the last quarter. Quantbot Technologies LP bought a new stake in Stevanato Group during the 3rd quarter valued at $68,000. Fifth Third Bancorp increased its holdings in shares of Stevanato Group by 22.6% in the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after acquiring an additional 773 shares during the period. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Stevanato Group by 1,268.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock valued at $112,000 after acquiring an additional 4,250 shares during the period.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.